RANDI ROSE: Open Payments
NPI 1841699980 · NORWOOD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 9 payments from 8 companies in 2025. Trend: 2023 $184 · 2024 $42 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Sage Therapeutics, LLC | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
Products named: COBENFY, REXULTI, FANAPT, CAPLYTA, INVEGA SUSTENNA, ZURZUVAE, INGREZZA.
Industry payments across MA — which companies pay providers there.
